Literature DB >> 11069909

The role of disulfide bridge in the folding and stability of the recombinant human prion protein.

N R Maiti1, W K Surewicz.   

Abstract

It is believed that the critical step in the pathogenesis of transmissible spongiform encephalopathies is a transition of prion protein (PrP) from an alpha-helical conformation, PrP(C), to a beta-sheet-rich form, PrP(Sc). Native prion protein contains a single disulfide bond linking Cys residues at positions 179 and 214. To elucidate the role of this bridge in the stability and folding of the protein, we studied the reduced form of the recombinant human PrP as well as the variant of PrP in which cysteines were replaced with alanine residues. At neutral pH, the reduced prion protein and the Cys-free mutant were insoluble and formed amorphous aggregates. However, the proteins could be refolded in a monomeric form under the conditions of mildly acidic pH. Spectroscopic experiments indicate that the monomeric Cys-free and reduced PrP have molten globule-like properties, i.e. they are characterized by compromised tertiary interactions, an increased exposure of hydrophobic surfaces, lack of cooperative unfolding transition in urea, and partial loss of native (alpha-helical) secondary structure. In the presence of sodium chloride, these partially unfolded proteins undergo a transition to a beta-sheet-rich structure. However, this transition is invariably associated with protein oligomerization. The present data argue against the notion that reduced prion protein can exist in a stable monomeric form that is rich in beta-sheet structure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069909     DOI: 10.1074/jbc.M007862200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  Molecular dynamics simulation of dimeric and monomeric forms of human prion protein: insight into dynamics and properties.

Authors:  Masakazu Sekijima; Chie Motono; Satoshi Yamasaki; Kiyotoshi Kaneko; Yutaka Akiyama
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

3.  Direct observation of multiple misfolding pathways in a single prion protein molecule.

Authors:  Hao Yu; Xia Liu; Krishna Neupane; Amar Nath Gupta; Angela M Brigley; Allison Solanki; Iveta Sosova; Michael T Woodside
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

4.  Conformational pH dependence of intermediate states during oligomerization of the human prion protein.

Authors:  Remo Gerber; Abdessamad Tahiri-Alaoui; P J Hore; William James
Journal:  Protein Sci       Date:  2008-01-24       Impact factor: 6.725

5.  Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms.

Authors:  Silvia Lisa; Beatriz Domingo; Javier Martínez; Sabine Gilch; Juan F Llopis; Hermann M Schätzl; María Gasset
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

6.  Single-molecule approaches to prion protein misfolding.

Authors:  Hao Yu; Derek R Dee; Michael T Woodside
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

7.  Genetic Incorporation of the Unnatural Amino Acid p-Acetyl Phenylalanine into Proteins for Site-Directed Spin Labeling.

Authors:  Eric G B Evans; Glenn L Millhauser
Journal:  Methods Enzymol       Date:  2015-07-02       Impact factor: 1.600

8.  Thermodynamic characterization of the unfolding of the prion protein.

Authors:  Roumita Moulick; Jayant B Udgaonkar
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

Review 9.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

10.  Global cell surface conformational shift mediated by a Candida albicans adhesin.

Authors:  Jason M Rauceo; Nand K Gaur; Kyeng-Gea Lee; John E Edwards; Stephen A Klotz; Peter N Lipke
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.